How has our approach to the treatment of frail, older patients with atrial fibrillation evolved?

Back

Open Access

How has our approach to the treatment of frail, older patients with atrial fibrillation evolved?

Session: The beginning of the end for NOACs? The extra mile

Topic: Atrial Fibrillation (AF)

Speaker: Doctor M. Patel (Durham, US) Doctor C. Coleman (Storrs, US) Associate Professor E. Arbelo (Barcelona, ES)

About the speakers

Doctor Manesh Patel

Duke University Medical Center, Durham (United States of America)

30 presentations

1 follower

Doctor Craig Coleman

University of Connecticut, Storrs (United States of America)

10 presentations

0 follower

Associate Professor Elena Arbelo

Hospital Clinic, University of Barcelona, Barcelona (Spain)

38 presentations

22 followers

6 more presentations in this session

Introduction.

Speaker: Doctor M. Patel (Durham, US)

Access

Understanding the impact of NOACs on the treatment of venous thromboembolism in vulnerable patients.

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE) Doctor M. Patel (Durham, US) Professor C. Becattini (Perugia, IT)

Access

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?

Speaker: Doctor M. Patel (Durham, US) Doctor C. Coleman (Storrs, US) Associate Professor E. Arbelo (Barcelona, ES)

Access

Valuing patient quality of life: treatment of cancer-associated thrombosis and extended therapy.

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE) Doctor M. Patel (Durham, US) Professor C. Becattini (Perugia, IT)

Access

Live Q&A.

Access

Access the full session

The beginning of the end for NOACs? The extra mile

Speakers: Doctor M. Patel, Doctor C. Coleman, Associate Professor E. Arbelo, Doctor M. Patel, Professor R. Bauersachs...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

How has our approach to the treatment of frail, older patients with atrial fibrillation evolved?

About the speakers

Doctor Manesh Patel

Doctor Craig Coleman

Associate Professor Elena Arbelo

6 more presentations in this session

Introduction.

Understanding the impact of NOACs on the treatment of venous thromboembolism in vulnerable patients.

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?​

Valuing patient quality of life: treatment of cancer-associated thrombosis and extended therapy.

Live Q&A.

Access the full session

The beginning of the end for NOACs? The extra mile​

About the event

ESC Congress 2022

ESC 365 is supported by

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?

The beginning of the end for NOACs? The extra mile